EN, S., AA, J., A, D., R, T., B, B., SR, R., . . . CM, L. (2023). Systematic Critical Review of Genetic Factors Associated with Cisplatin-induced Ototoxicity: Canadian Pharmacogenomics Network for Drug Safety 2022 Update. Therapeutic drug monitoring, 45(6), 714. https://doi.org/10.1097/FTD.0000000000001113
Chicago Style (17th ed.) CitationEN, Scott, Joseph AA, Dhanda A, Tanoshima R, Brooks B, Rassekh SR, Ross CJD, Carleton BC, and Loucks CM. "Systematic Critical Review of Genetic Factors Associated with Cisplatin-induced Ototoxicity: Canadian Pharmacogenomics Network for Drug Safety 2022 Update." Therapeutic Drug Monitoring 45, no. 6 (2023): 714. https://doi.org/10.1097/FTD.0000000000001113.
MLA (9th ed.) CitationEN, Scott, et al. "Systematic Critical Review of Genetic Factors Associated with Cisplatin-induced Ototoxicity: Canadian Pharmacogenomics Network for Drug Safety 2022 Update." Therapeutic Drug Monitoring, vol. 45, no. 6, 2023, p. 714, https://doi.org/10.1097/FTD.0000000000001113.